Yiwei Lin
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
Papers in
-
- Epigenetics and DNA Methylation 10
- Cancer-related gene regulation 6
- RNA Interference and Gene Delivery 2
- Metabolism, Diabetes, and Cancer 2
- Oncology 9
- Cancer Cells and Metastasis 4
- Co-authors
- Binhua P. Zhou (7 shared papers)Chenfang Dong (4 shared papers)Yadi Wu (3 shared papers)Tiebang Kang (3 shared papers)Jun Yao (2 shared papers)Liping Xie (16 shared papers)Junlin Li (2 shared papers)Qiqi Mao (11 shared papers)
- Journals
- World Journal of Surgical Oncology (4 papers)Cancer Cell (2 papers)Cell Cycle (2 papers)Oncotarget (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yiwei Lin
42 papers receiving 2.4k citations
Yiwei Lin's Hit Papers
Peers
Comparison fields: 5 of 98
- Cancer Research 642
- Molecular Biology 1.7k
- Oncology 628
- Hematology 138
- Geriatrics and Gerontology 37
Countries citing papers authored by Yiwei Lin
This map shows the geographic impact of Yiwei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Lin more than expected).
Fields of papers citing papers by Yiwei Lin
This network shows the impact of papers produced by Yiwei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Lin. The network helps show where Yiwei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiwei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer Hit paper breakdown → | 2013 | 655 |
| 2 | 2014 | 388 | |
| 3 | 2010 | 297 | |
| 4 | 2017 | 118 | |
| 5 | 2014 | 111 | |
| 6 | 2013 | 76 | |
| 7 | 2014 | 59 | |
| 8 | 2013 | 56 | |
| 9 | 2017 | 54 | |
| 10 | 2012 | 53 | |
| 11 | 2011 | 52 | |
| 12 | 2017 | 49 | |
| 13 | IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications. | 2021 | 36 |
| 14 | 2013 | 35 | |
| 15 | 2010 | 34 | |
| 16 | 2012 | 33 | |
| 17 | 2014 | 32 | |
| 18 | 2023 | 29 | |
| 19 | 2013 | 28 | |
| 20 | 2013 | 26 |
About Yiwei Lin
Yiwei Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pharmacology, having authored 43 papers that have together received 2.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (6 papers), Cancer Cells and Metastasis (4 papers), Flavonoids in Medical Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Urologic and reproductive health conditions (2 papers), RNA Interference and Gene Delivery (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (642 citations), Molecular Biology (1.7k citations), Oncology (628 citations), Hematology (138 citations) and Geriatrics and Gerontology (37 citations). Yiwei Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Binhua P. Zhou, Chenfang Dong, Yadi Wu, Tiebang Kang, Jun Yao, Liping Xie, Junlin Li, Qiqi Mao, B. Mark Evers and Daret St. Clair. Their work appears in journals such as World Journal of Surgical Oncology, Cancer Cell, Cell Cycle, Oncotarget and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.